Alicia Granados, MD & PhD in Public Health from the University of Barcelona is a certified specialist in
respiratory medicine. Currently serving as Head of Global Rare Diseases Medical Scientific Advocacy at
Sanofi, where she has been heading its global HTA strategy until 2021).
She was a founding member of INAHTA, the first international HTA network; as well as the first HTA joint
initiative in Europe, EUR-ASSESS, predecessor of EUnetHTA. She is also former President of the
International Society for Technology Assessment in Health Care (ISTAHC) and Chair of the Committee for
the Creation of a new HTA Society: HTAi, of which she was the first president. Currently serving, on a
voluntary basis, as Chair of the HTAi Policy Forum Series, Advisory Committee.
Dr. Granados has been temporary advisor of several UN agencies on Evidence Based Health Care, and
Acting Regional Advisor of WHO European Office, leading the Health Evidence Network. She has been
Associate Professor of Medicine at the University of Barcelona and has more than 60 scientific and policy
articles published. Dr. Granados is former President of Autonomous University of Barcelona’s Board of
Trustees, Advisor to the Catalan Government President on wellness and economic reactivation and
growth (CAREC) and of the Department of Health Advisory Council of Catalan Government.